Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.940 USD | +1.79% | -1.12% | -17.89% |
07-25 | Garrett Motion Shares Fall After Company Posts Lower Q2 Net Sales, Cuts 2024 Revenue Guidance | MT |
07-25 | Transcript : Garrett Motion Inc., Q2 2024 Earnings Call, Jul 25, 2024 |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|
Revenues | 3.25B | 3.03B | 3.63B | 3.6B | 3.89B | ||||
Total Revenues | 3.25B | 3.03B | 3.63B | 3.6B | 3.89B | ||||
Cost of Goods Sold, Total | 2.54B | 2.47B | 2.91B | 2.92B | 3.13B | ||||
Gross Profit | 713M | 566M | 723M | 687M | 756M | ||||
Selling General & Admin Expenses, Total | 229M | 280M | 203M | 179M | 240M | ||||
Other Operating Expenses | - | 2M | - | - | - | ||||
Other Operating Expenses, Total | 229M | 282M | 203M | 179M | 240M | ||||
Operating Income | 484M | 284M | 520M | 508M | 516M | ||||
Interest Expense, Total | -68M | -79M | -93M | -82M | -159M | ||||
Interest And Investment Income | 7M | 3M | 11M | 76M | 7M | ||||
Net Interest Expenses | -61M | -76M | -82M | -6M | -152M | ||||
Income (Loss) On Equity Invest. | 6M | 5M | 7M | 7M | 7M | ||||
Currency Exchange Gains (Loss) | -13M | 35M | -14M | -3M | -6M | ||||
Other Non Operating Income (Expenses) | -1M | -2M | -2M | 2M | -18M | ||||
EBT, Excl. Unusual Items | 415M | 246M | 429M | 508M | 347M | ||||
Restructuring Charges | -2M | -10M | -16M | -4M | - | ||||
Legal Settlements | -11M | -3M | - | - | - | ||||
Other Unusual Items | -56M | -114M | 125M | -8M | - | ||||
EBT, Incl. Unusual Items | 346M | 119M | 538M | 496M | 347M | ||||
Income Tax Expense | 33M | 39M | 43M | 106M | 86M | ||||
Earnings From Continuing Operations | 313M | 80M | 495M | 390M | 261M | ||||
Net Income to Company | 313M | 80M | 495M | 390M | 261M | ||||
Net Income - (IS) | 313M | 80M | 495M | 390M | 261M | ||||
Preferred Dividend and Other Adjustments | - | - | 377M | 341M | 312M | ||||
Net Income to Common Incl Extra Items | 313M | 80M | 118M | 49M | -51M | ||||
Net Income to Common Excl. Extra Items | 313M | 80M | 118M | 49M | -51M | ||||
Per Share Items | |||||||||
Net EPS - Basic | 4.2 | 1.06 | 1.69 | 0.76 | -0.31 | ||||
Basic EPS - Continuing Operations | 4.2 | 1.06 | 1.69 | 0.76 | -0.31 | ||||
Basic Weighted Average Shares Outstanding | 74.6M | 75.54M | 69.71M | 64.71M | 167M | ||||
Net EPS - Diluted | 4.12 | 1.05 | 1.56 | 0.75 | -0.31 | ||||
Diluted EPS - Continuing Operations | 4.12 | 1.05 | 1.56 | 0.75 | -0.31 | ||||
Diluted Weighted Average Shares Outstanding | 75.93M | 76.1M | 318M | 65.08M | 167M | ||||
Normalized Basic EPS | 3.48 | 2.04 | 3.85 | 4.91 | 1.3 | ||||
Normalized Diluted EPS | 3.42 | 2.02 | 0.84 | 4.88 | 1.3 | ||||
Payout Ratio | - | - | - | 21.28 | 16.09 | ||||
Supplemental Items | |||||||||
EBITDA | 557M | 370M | 612M | 592M | 606M | ||||
EBITA | 484M | 284M | 520M | 508M | 516M | ||||
EBIT | 484M | 284M | 520M | 508M | 516M | ||||
EBITDAR | 571M | 385M | 627M | 608M | 622M | ||||
Effective Tax Rate - (Ratio) | 9.54 | 32.77 | 7.99 | 21.37 | 24.78 | ||||
Current Domestic Taxes | - | - | -1M | 10M | 12M | ||||
Current Foreign Taxes | - | - | 80M | 50M | 50M | ||||
Total Current Taxes | 74M | 73M | 79M | 60M | 62M | ||||
Deferred Domestic Taxes | - | - | -11M | 9M | -13M | ||||
Deferred Foreign Taxes | - | - | -25M | 37M | 37M | ||||
Total Deferred Taxes | -41M | -34M | -36M | 46M | 24M | ||||
Normalized Net Income | 259M | 154M | 268M | 318M | 217M | ||||
Interest on Long-Term Debt | - | - | - | 82M | 159M | ||||
Non-Cash Pension Expense | 8M | 5M | -12M | -37M | -7M | ||||
Supplemental Operating Expense Items | |||||||||
Research And Development Expense From Footnotes | 134M | 124M | 158M | 164M | 209M | ||||
Net Rental Expense, Total | 14M | 15M | 15M | 16M | 16M | ||||
Imputed Operating Lease Interest Expense | 5.01M | 5.28M | 5.91M | 7.41M | 14.06M | ||||
Imputed Operating Lease Depreciation | 8.99M | 9.72M | 9.09M | 8.59M | 1.94M | ||||
Stock-Based Comp., SG&A Exp. (Total) | 18M | 17M | 11M | 11M | 14M | ||||
Stock-Based Comp., Other (Total) | - | - | 13M | - | - | ||||
Total Stock-Based Compensation | 18M | 17M | 24M | 11M | 14M |